{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:07:05Z","timestamp":1774040825047,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pac J Clncl Oncology"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depth of response prior to autologous stem cell transplantation (ASCT) has been associated with improved progression\u2010free survival (PFS) in multiple myeloma (MM). This study aimed to evaluate the impact of pre\u2010transplant response depth on post\u2010transplant outcomes in patients with multiple myeloma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and methods<\/jats:title>\n                    <jats:p>This retrospective multicenter analysis, conducted by the Pakistan Blood and Marrow Transplant group, included 223\u00a0MM patients treated over 18 years across six centers. Pre\u2010transplant responses were classified using International Myeloma Working Group criteria. Overall survival (OS) and disease\u2010free survival (DFS) were estimated using Kaplan\u2010Meier methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort had a mean age of 49 years, with 70.4% males. Back pain (56%) and pathological fractures (15%) were common presenting features. Anemia and renal impairment were noted in 45% and 26%, respectively. The predominant paraprotein subtype was IgG kappa (31%). ISS staging revealed that 33.3% of patients had stage I, 27.4% stage II, and 37.6% stage III disease. Induction therapy included RVd in 42% and CyBorD in 41% of patients. Post\u2010induction responses showed complete stringent response (sCR) in 7.4%, complete response (CR) in 22%, very good partial response (VGPR) in 19%, and partial response (PR) in 18%. Age less than 50 years, favorable induction response, and achieving VGPR or more before ASCT were significantly associated with improved outcomes. At the time of transplant, 58.3% had sCR\/CR and 20.2% had VGPR. Median OS was 72.4% at a median of 72 months, while DFS was 57% at a median of 47 months. Patients with sCR\/CR prior to ASCT had significantly better OS and DFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In resource\u2010constrained settings, achieving a deeper response before ASCT is associated with superior survival outcomes in MM. Optimizing induction to attain at least VGPR may enhance the benefit of transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ajco.70104","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:19:03Z","timestamp":1774034343000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Pre\u2010Transplant\u00a0Depth of Response on Outcomes in Patients With Multiple Myeloma: A Report on Behalf of Pakistan Blood and Marrow Transplant Group"],"prefix":"10.1111","author":[{"given":"Natasha","family":"Ali","sequence":"first","affiliation":[{"name":"The Aga Khan University Hospital  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyal","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Shifa International Hospital  Islamabad Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheel","family":"Iftikhar","sequence":"additional","affiliation":[{"name":"Armed Forces Bone Marrow Transplant Centre  Rawalpindi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Iftikhar","sequence":"additional","affiliation":[{"name":"Shifa International Hospital  Islamabad Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nida","family":"Anwar","sequence":"additional","affiliation":[{"name":"National Institute of Blood Diseases and Bone Marrow Transplant  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Waqas","family":"Bokhari","sequence":"additional","affiliation":[{"name":"Shaukat Khanum Memorial Cancer Hospital and Research Center  Lahore Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzma","family":"Zaidi","sequence":"additional","affiliation":[{"name":"National Institute of Blood Diseases and Bone Marrow Transplant  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Shaukat Khanum Memorial Cancer Hospital and Research Center  Lahore Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad","family":"Sarwar","sequence":"additional","affiliation":[{"name":"Gambat Institute of Medical Sciences  Sukkur Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saima","family":"Humayun","sequence":"additional","affiliation":[{"name":"Armed Forces Bone Marrow Transplant Centre  Rawalpindi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Khan","sequence":"additional","affiliation":[{"name":"Armed Forces Bone Marrow Transplant Centre  Rawalpindi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Ahsan","sequence":"additional","affiliation":[{"name":"Shaukat Khanum Memorial Cancer Hospital and Research Center  Lahore Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrukh Ali","family":"Khan","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Jamal","sequence":"additional","affiliation":[{"name":"National Institute of Blood Diseases and Bone Marrow Transplant  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawad","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munira","family":"Moosajee","sequence":"additional","affiliation":[{"name":"The Aga Khan University Hospital  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar","family":"Zahur","sequence":"additional","affiliation":[{"name":"Quaid e Azam International Hospital  Islamabad Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munira","family":"Borhany","sequence":"additional","affiliation":[{"name":"Ziauddin Hospital  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman Naseem","family":"Adil","sequence":"additional","affiliation":[{"name":"The Aga Khan University Hospital  Karachi Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ayaz","family":"Mir","sequence":"additional","affiliation":[{"name":"Shifa International Hospital  Islamabad Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"12","key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma","volume":"15","author":"Rajkumar S. V.","year":"2014","journal-title":"Lancet Oncology"},{"issue":"1","key":"e_1_2_8_3_1","first-page":"12","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel R. L.","year":"2024","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"e_1_2_8_4_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009584","article-title":"Incidence of multiple myeloma in Great Britain, Sweden, and Malmo, Sweden: The Impact of Differences in Case Ascertainment on Observed Incidence Trends","volume":"6","author":"Velez R.","year":"2016","journal-title":"Bmj Open"},{"issue":"2","key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12288-021-01485-y","article-title":"A Multicenter Study of Clinical Presentations and Outcomes of Multiple Myeloma in Pakistan: The Real\u2010World Analysis in a Resource\u2010Constrained Country","volume":"38","author":"Saeed N.","year":"2022","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"issue":"3","key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/cam4.5239","article-title":"Duration of Frontline Therapy and Impact on Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients Not Receiving Frontline Stem Cell Transplant","volume":"12","author":"Ailawadhi S.","year":"2023","journal-title":"Cancer Medicine"},{"issue":"31","key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1200\/JCO.2007.11.7879","article-title":"Relationship Between Depth of Response and Outcome in Multiple Myeloma","volume":"25","author":"Dingli D.","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14196\/mjiri.32.1","article-title":"Characteristics and Outcomes of Patients With Multiple Myeloma: Data From a Developing Country","volume":"32","author":"Hameed A.","year":"2018","journal-title":"Medical Journal of The Islamic Republic of Iran"},{"issue":"23","key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1182\/blood-2011-02-297325","article-title":"International Myeloma Working Group Consensus Approach to the Treatment of Multiple Myeloma Patients Who Are Candidates for Autologous Stem Cell Transplantation","volume":"117","author":"Cavo M.","year":"2011","journal-title":"Blood"},{"issue":"4","key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hemonc.2017.05.005","article-title":"Recent Advances in Understanding Multiple Myeloma","volume":"10","author":"Hari P.","year":"2017","journal-title":"Hematology\/Oncology and Stem Cell Therapy"},{"issue":"36","key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1200\/JCO.2013.49.0086","article-title":"Importance of Achieving Stringent Complete Response After Autologous Stem\u2010cell Transplantation in Multiple Myeloma","volume":"31","author":"Kapoor P.","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.7314\/APJCP.2016.17.4.1833","article-title":"Multiple Myeloma: A Retrospective Analysis of 61 Patients From a Tertiary Care Center","volume":"17","author":"Sultan S.","year":"2016","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"16","key":"e_1_2_8_13_1","first-page":"14","article-title":"Multiple Myeloma: A Clinical and Pathological Profile","volume":"1","author":"Kaur P.","year":"2014","journal-title":"Gulf Journal of Oncology"},{"key":"e_1_2_8_14_1","first-page":"10","article-title":"The Epidemiological Features of Lymphoid Malignancies in Benin City, Nigeria: A 15 Years Study","volume":"11","author":"Omoti C. E.","year":"2012","journal-title":"Pan African Medical Journal"},{"issue":"2","key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bjh.14213","article-title":"Multiple Myeloma: Patient Outcomes in Real\u2010world Practice","volume":"175","author":"Yong K.","year":"2016","journal-title":"British Journal of Haematology"},{"issue":"1","key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3816\/CLM.2003.s.005","article-title":"The Implications of Anemia in Multiple Myeloma","volume":"4","author":"Mittelman M.","year":"2003","journal-title":"Clinical Lymphoma"},{"issue":"3","key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7861\/clinmed.2022-0144","article-title":"Multiple Myeloma: What a Non\u2010haematologist Should Know","volume":"22","author":"Nandra T. K.","year":"2022","journal-title":"Clinical Medicine"},{"issue":"1","key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12913-019-4521-3","article-title":"Health Seeking Behaviour, Delayed Presentation and Its Impact Among Oral Cancer Patients in Pakistan: A Retrospective Qualitative Study","volume":"19","author":"Basharat S.","year":"2019","journal-title":"BMC Health Services Research [Electronic Resource]"},{"issue":"21","key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2016-01-693580","article-title":"VTD Is Superior to VCD Prior to Intensive Therapy in Multiple Myeloma: Results of the Prospective IFM2013\u201004 Trial","volume":"127","author":"Moreau P.","year":"2016","journal-title":"Blood"},{"issue":"3","key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hon.2729","article-title":"Real World Outcomes With Bortezomib Thalidomide Dexamethasone and Cyclophosphamide Bortezomib Dexamethasone Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. A Retrospective Cohort Study From Grupo Argentino De Mieloma Multiple","volume":"38","author":"Schutz N. P.","year":"2020","journal-title":"Hematological Oncology"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211019612","article-title":"The Role of carfilzomib in Relapsed\/Refractory Multiple Myeloma","volume":"12","author":"Yee A. J.","year":"2021","journal-title":"Therapeutic Advances in Hematology"},{"issue":"10","key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.bmt.1703717","article-title":"Response to Induction Chemotherapy Is Not Essential to Obtain Survival Benefit From High\u2010dose Melphalan and Autotransplantation in Myeloma","volume":"30","author":"Singhal S.","year":"2002","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1704545","article-title":"High\u2010dose Therapy and Autologous Stem Cell Transplantation for Multiple Myeloma Poorly Responsive to Initial Therapy","volume":"34","author":"Kumar S.","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"26","key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus Double Autologous Stem\u2010cell Transplantation for Multiple Myeloma","volume":"349","author":"Attal M.","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbmt.2008.12.512","article-title":"Complete Remission Status Before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients With Multiple Myeloma Undergoing Upfront Single Autologous Transplantation","volume":"15","author":"Kim J. S.","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"10","key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/COC.0000000000000408","article-title":"\u201cLost to Follow\u2010up\u201d among Adult Cancer Survivors","volume":"41","author":"Gill A.","year":"2018","journal-title":"American Journal of Clinical Oncology"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajco.70104","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajco.70104","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajco.70104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:19:07Z","timestamp":1774034347000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajco.70104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":25,"alternative-id":["10.1111\/ajco.70104"],"URL":"https:\/\/doi.org\/10.1111\/ajco.70104","archive":["Portico"],"relation":{},"ISSN":["1743-7555","1743-7563"],"issn-type":[{"value":"1743-7555","type":"print"},{"value":"1743-7563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2025-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ajco.70104"}}